Mini symposium. The major histocompatibility complex in pregnancy: Part II. Placental HLA-G protein expression in vivo: where and what for?
Open Access
- 1 May 1999
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 5 (3) , 223-233
- https://doi.org/10.1093/humupd/5.3.223
Abstract
In contrast to HLA-A and -B class Ia genes that are down-regulated in human trophoblast cells, HLA-G class Ib molecules are expressed in the placenta throughout gestation. In addition to extravillous cytotrophoblast that invade the decidua basalis essentially, HLA-G was also observed in endothelial cells of fetal vessels in the chorionic villi as well as in amnion cells and amniotic fluid. Both membrane-bound and soluble HLA-G isoforms have been detected. In view of the recently published functional data showing that HLA-G: (i) has the capability to bind and present peptides; (ii) is recognized by at least three different killing inhibitory receptors; and (iii) is a regulator of HLA-E expression, we can predict that such functions are likely to be exerted by extravillous cytotrophoblast. Of particular importance will be the anti-viral function of HLA-G at this materno-fetal interface, knowing that HLA-G was shown to be expressed by thymic medullary epithelial cells. In addition to these immunological functions, due to its presence on chorionic fetal endothelial cells, we hypothesize that HLA-G could also be a regulator of chorionic villous angiogenesis. Finally, soluble HLA-G isoforms may act as specific immunosuppressors during pregnancy. Keywords:cytotoxic T cells/endothelial cells/HLA-G/NK cell receptors/trophoblastKeywords
This publication has 0 references indexed in Scilit: